Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 5/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL42580 | 0.94 | SLC18A3 (0.61) | SLC18A3SIGMAR1CYP2D6TRPA1CYP2C19 | |
| Hydrochloric Acid SCHEMBL8036483 | 0.92 | SLC18A3 (0.58) | SLC18A3SIGMAR1CYP2D6TRPA1CYP2C19 | |
| SCHEMBL42833 | 0.92 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP2D6TRPA1CYP2C19 | |
| SCHEMBL19262690 | 0.92 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP2D6TRPA1CYP2C19 | |
| SCHEMBL447032 | 0.92 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP2D6TRPA1CYP2C19 | |
| Hydrogen Peroxide SCHEMBL2352938 | 0.92 | SLC18A3 (0.58) | SLC18A3SIGMAR1CYP2D6TRPA1CYP1A2 | |
| SCHEMBL11562787 | 0.92 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP2D6TRPA1CYP2C19 | |
| SCHEMBL790829 | 0.92 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP2D6TRPA1CYP2C19 | |
| SCHEMBL19198566 | 0.92 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP2D6TRPA1CYP2C19 | |
| SCHEMBL30731352 | 0.92 | SLC18A3 (0.63) | SLC18A3SIGMAR1CYP2D6TRPA1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 801 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119842444-A | Method for improving oxidation resistance and/or ultraviolet resistance of tea oil and application thereof | 楠员木(厦门)生物科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-116102478-B | Preparation method of 1, 4-dicarbonyl thiosemicarbazide compound and anti-infection application | 中国医学科学院药物研究所 | 2025-04-15 | — | — | CN | claimed |
| US-20240109866-A1 | MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF | Crinetics Pharmaceuticals, Inc. | 2024-04-04 | — | — | US | claimed |
| CN-116102478-A | Preparation method of 1, 4-dicarbonyl thiosemicarbazide compound and anti-infection application | 中国医学科学院药物研究所 | 2023-05-12 | — | — | CN | claimed |
| EP-4165033-A1 | SHP2 INHIBITORS, COMPOSITIONS AND USES THEREOF | Betta Pharmaceuticals Co., Ltd (CN) | 2023-04-19 | — | — | EP | claimed |
| CN-115851038-A | Ternary solvent-based red quantum dot ink-jet ink and preparation method thereof | 北京印刷学院 | 2023-03-28 | — | — | CN | claimed |
| CN-112094535-B | Ink formulation, photovoltaic device, and method of making the same | 纳晶科技股份有限公司 | 2022-09-09 | — | — | CN | claimed |
| US-11299648-B2 | Polymer, coating composition comprising same, and organic light emitting diode using same | LG CHEM, LTD. | 2022-04-12 | — | — | US | claimed |
| WO-2021249449-A1 | SHP2 INHIBITORS, COMPOSITIONS AND USES THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2021-12-16 | — | — | WO | claimed |
| CN-113122054-A | Preparation method of ink and quantum dot film | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| WO-1995007901-A1 | SUBSTITUTED TETRONIC ACIDS USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | THE UPJOHN COMPANY (US) | 1995-03-23 | — | — | WO | claimed |
| WO-1994001388-A1 | CYCLOBUTABENZENE MONOMERS AND METHODS OF MAKING AND USING SAME | UNIVERSITY OF MICHIGAN (US) | 1994-01-20 | — | — | WO | claimed |
| US-4833143-A | PHENYL CYCLOBUTYL HETEROCYCLIC AMINES AND AMIDES | THE BOOTS COMPANY PLC (GB) | 1989-05-23 | — | — | US | claimed |
| EP-0031708-B1 | CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR | ICI PHARMA (FR) | 1984-06-13 | — | — | EP | claimed |
| US-4394385-A | ANTIEDEMIC AGENTS; BRAIN INJURIES; NERVOUS SYSTEM DISORDERS | MERCK & CO., INC. (US) | 1983-07-19 | — | — | US | claimed |
| EP-0075434-A2 | Cephalosporins, their preparation and their pharmaceutical compositions | ICI PHARMA (FR) | 1983-03-30 | — | — | EP | claimed |
| EP-0071370-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | ICI PHARMA (FR) | 1983-02-09 | — | — | EP | claimed |
| EP-0002620-B1 | CYCLOALKYL CARBOXYLIC ESTERS, INSECTICIDAL COMPOSITIONS CONTAINING THEM, AND METHODS FOR THEIR PREPARATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1981-11-25 | — | — | EP | claimed |
| EP-0031708-A2 | Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor | ICI PHARMA (FR) | 1981-07-08 | — | — | EP | claimed |
| EP-0002620-A1 | Cycloalkyl carboxylic esters, insecticidal compositions containing them, and methods for their preparation | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1979-06-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240109866-A1 | MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF | MC3R, MC1R, MC2R | SLC18A3 641/4885SIGMAR1 516/4885CYP2D6 1931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.